文献速递医学教育与科研方法流行病学与生物统计

中学健康选择干预1年后的效果:基于个体参与者数据的前瞻性Meta分析

Effects of the informed health choices secondary school intervention after 1 year: a prospective meta-analysis using individual participant data.
PubMed 文献 · Trials · 2024-10-30

该前瞻性Meta分析汇总了肯尼亚、卢旺达和乌干达三项整群随机试验的1年随访数据,评估教授初中生批判性思考健康选择干预的效果。干预包括2-3天教师培训工作坊和十节课的数字资源,聚焦九个关键概念。1年后干预组通过测试的比值比为3.6(95%CI 1.9-7.1),学习保留率为88.3%。

要点

  • 1年后干预组通过测试的比值比为3.6(95%CI 1.9-7.1;p=0.0001),优于对照组。
  • 干预刚结束时通过测试的比值比为5.5(95%CI 3.0-10.2),1年后效果有所下降。
  • 1年后干预组通过率为52.6%(2273/4324),学习保留率为88.3%。

核心结论

  • 干预1年后,学生在批判性思考健康选择的能力上仍存在积极效果,但干预学校通过测试的学生比例较干预刚结束时减少了5.5%。
  • 由于27%的学生失访,证据确定性较低。

研究设计与样本

  • 前瞻性Meta分析,汇总三项在肯尼亚、卢旺达和乌干达开展的整群随机试验的1年随访个体参与者数据。
  • 共244所学校、11344名学生参与三项试验,收集到8298名学生的随访数据(73%)。
  • 干预包括提供2-3天教师培训工作坊和十节课的数字资源,聚焦九个关键概念;对照学校未实施干预。
  • 主要结局为测试通过(18道多选题中至少答对9题)。

主要发现

  • 1年后主要结局的总体比值比为3.6(95%CI 1.9-7.1;p=0.0001),有利于干预组;干预刚结束时为5.5(95%CI 3.0-10.2)。
  • 1年后干预学校通过测试的学生比例较对照组高25.6%(95%CI 21.1-30.0%),干预刚结束时高33.3%(95%CI 28.7-37.8%)。
  • 1年后干预学校4324名学生中2273名(52.6%)通过测试,干预刚结束时5846名学生中3397名(58.1%)通过,学习保留率为88.3%。

关键数值与推荐

  • 主要结局通过定义为18道多选题中至少答对9题。
  • 1年后干预组通过率为52.6%(2273/4324),干预刚结束时为58.1%(3397/5846)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 27%的学生失访,导致证据确定性较低。
  • 1年后干预学校通过测试的学生比例较干预刚结束时减少5.5%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critical thinking about health choices is essential to avoid being misled by unreliable information and to use reliable information appropriately. The aim of this prospective meta-analysis was to synthesize the results of 1-year follow-up data from three cluster-randomized trials of an intervention designed to teach lower secondary school students to think critically about health choices. Only one other randomized trial has evaluated a school-based intervention to teach adolescents to think critically about health choices. That trial compared two teaching strategies to teach statistical reasoning. It did not assess long-term learning-retention. METHODS: We conducted the trials in Kenya, Rwanda, and Uganda. The intervention included providing a 2-3-day teacher training workshop and digital resources for ten lessons. The intervention focused on nine key concepts. We did not intervene in control schools. The primary outcome was a passing score on a test (≥ 9 of 18 multiple-choice questions answered correctly). We performed random effects meta-analyses to estimate the overall intervention effects. We calculated learning retention as the test results in the intervention schools after 1 year relative to just after the intervention, adjusted for chance. RESULTS: Altogether, 244 schools (11,344 students) took part in the three trials. Follow-up data was collected for 8298 students (73%). The overall odds ratio for the primary outcome after 1 year was 3.6 (95% CI: 1.9-7.1; p = 0.0001) in favor of the intervention, whereas it was 5.5 (95% CI: 3.0-10.2) just after the intervention. This corresponds to 25.6% (95% CI: 21.1-30.0%) more students in the intervention schools passing the test after 1 year versus 33.3% (95% CI: 28.7-37.8%) just after the intervention. Overall, 2273 (52.6%) of 4324 students in intervention schools had a passing score after 1 year compared to 3397 (58.1%) of 5846 students just after the intervention, indicating 88.3% learning retention. CONCLUSIONS: One year after the intervention, we still found a positive effect on the ability of students to think critically about health choices, but 5.5% fewer students in the intervention schools had a passing score. The certainty of the evidence was also lower due to 27% of students being lost to follow-up. TRIAL REGISTRATION: The protocol for this prospective meta-analysis was registered with PROSPERO May 31, 2022, ID 336580. The three randomized trials were registered in the Pan African Clinical Trial Registry February 15, 2022, PACTR202203880375077; April 5, 2022, PACTR20220488391731; and April 14, 2022, PACTR202204861458660.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chesire F, Mugisha M, Ssenyonga R, et al. Effects of the informed health choices secondary school intervention after 1 year: a prospective meta-analysis using individual participant data. Trials. 2024. PMID: 39478569. doi:10.1186/s13063-024-08577-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。